Insulin aspart(aspB28 human insulin) derivatives formed in pharmaceutical solutions

Pharmaceutical Research

Volumn 19, Issue 5, 2002, Pages 621-628

  Jars, Mette Uve ^a   Hvass, Aage ^a   Waaben, Dorte ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

AspB28 human insulin derivatives; AspB28, desPheB1 N oxalyl ValB2 human insulin; Deamidation; IsoAspB28 human insulin; Isomerization

Indexed keywords

INSULIN ASPART; SUCCINIMIDE DERIVATIVE; DRUG DERIVATIVE; INSULIN; INSULIN, ASP(B28)-;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DEAMINATION; DRUG POTENCY; DRUG SYNTHESIS; ISOMERISM; MASS SPECTROMETRY; PEPTIDE MAPPING; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; DRUG STABILITY; DRUG STORAGE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLUTION AND SOLUBILITY;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG STORAGE; INSULIN; PEPTIDE MAPPING; PHARMACEUTICAL SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0036001392     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015302012070     Document Type: Article

References (32)

1. Insulin analogs with improved pharmacokinetic profiles
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
3. Monomeric insulins obtained by protein engineering and their medical implications
4. Monomeric insulins and their experimental and clinical implications
5. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I
6. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 Pro→Asp insulin analogues
7. Glycaemic control in IDDM patients during one day with injection of human insulin or the insulin analogues insulin X14 and insulin X14 (+Zn)
8. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: A randomized controlled trial
9. Chemical stability of insulin: 1. Hydrolytic degradation during storage of pharmaceutical preparations
10. Chemical stability of insulin: 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations
11. Chemical stability of insulin: 3. Influence of excipients, formulation, and pH
12. Chemical stability of insulin: 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation
13. Chemical stability of insulin: 5. Isolation, characterization and identification of insulin transformation products
14. Evidence for a common intermediate in insulin deamidation and covalent dimer formation: Effects of pH and aniline trapping in dilute acidic solutions
15. Solid-state stability of human insulin II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: Stabilization against covalent dimer formation
16. Isoaspartate in peptides and proteins: Formation, significance, and analysis
17. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins
18. Deamidation, isomerization and racemization at asparaginyl and aspartyl residues in peptides: Succinimide-linked reactions that contribute to protein degradation
19. Succinimide formation from aspartyl and asparaginyl peptides as model for the spontaneous degradation of proteins
20. The sequence of amino acid residues in bovine pancreatic ribonuclease: Revisions and confirmations
21. [117] Chromatographic determination of amino acids by the use of automatic recording equipment
22. A protein sequenator
23. Insulin preparations monograph proposals and rationale for modification
24. The denaturation and degradation of stable enzymes at high temperatures
25. Methylation at specific altered aspartyl and asparaginyl residues in glucagon by erythrocyte protein carboxyl methyltransferase
26. Phenol-promoted structural transformation of insulin in solution
27. New aspects of the Maillard reaction in foods and in the human body
28. Analytical chemistry of therapeutic proteins